Clinical amelioration (reduction of arthritis index and swollen joint count). Decrease of synovial hyperplasia, cartilage erosion, and inflammation mediated by induction of CD25+ FoxP3+ Treg and inhibition of Th17 cells. Here, FOXP3 is linked to arthritic joint disease.